Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease 2007-07-01
  2. Tau-like immunoreactivity in Alzheimer and control skin fibroblasts 1994-12-01

Studies

2 studies carry this tag.

Date range

1994 to 2007

Top journals

  • Journal of neuroscience research 1
  • Neurology 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

    ✓ Peer-reviewed alzhub usefulness score 82 out of 100. Neurology 2007-07-01 Treatments

    The rivastigmine patch is the first transdermal treatment for Alzheimer disease (AD).

  2. Tau-like immunoreactivity in Alzheimer and control skin fibroblasts

    ✓ Peer-reviewed alzhub usefulness score 36 out of 100. Journal of neuroscience research 1994-12-01 Drug development

    The presence of the microtubule-associated protein tau in skin fibroblasts derived from Alzheimer patients and normal controls was investigated using a panel of well-characterized anti-tau antibodies against epitopes spanning the tau protein from the amino to the carboxyl end.

All topic tags with their study counts